News

An Italian study that was recently published in Neurology, the official journal of the American Academy of Neurology, suggests that hematopoietic stem cell transplants may help persons having active secondary progressive multiple sclerosis (MS) delay disability. The ten-year retrospective study...

Multiple provisions crucial to FDA operations and authority, in addition to clinical research sponsors and pharmaceutical manufacturers, are included in the year-end, must-pass government spending bill. Along with dozens of measures involving drug development and regulation, the $1.7 billion...

The benefits of earlier detection and quicker access to treatments will be felt by cancer patients as well as newborns with curable but uncommon genetic illnesses. It comes after the UK health and social care secretary pledged a £175...

The first gene therapy for non-muscle invasive bladder cancer (NMIBC) in individuals with high-risk carcinoma in situ (CIS) with or without papillary tumours has been licenced by the US Food and Drug Administration (FDA) as Adstiladrin (nadofaragene firadenovec-vncg). Adstiladrin,...

Around the world, drug abuse is at record high levels, with rehabilitation centres seeing more people through their doors, particularly when it comes to opioid abuse. It’s a similar story across the likes of the USA, UK and recent...

The agency that suggests which medications should be allowed in Europe has backed five new ones, including a gene therapy for haemophilia, a combo treatment for liver cancer, and a drug for the uncommon condition known as Pompe disease. The...

The World Health Organization (WHO) has released its revised consolidated recommendations for treating drug-resistant tuberculosis (DR-TB), which include significant advancements in the treatment options available to individuals with MDR or RR-TB: multidrug-resistant or rifampicin-resistant tuberculosis) and a regimen that...